Australian scrutiny of prostheses performance extended:
This article was originally published in Clinica
Performance data of ankle, shoulder, wrist and spinal disc prostheses are to be added to data on hips and knees collected by Australia's National Joint Replacement Registry. The government has committed Aus$0.8m (US$0.7m) over four years to fund the expansion of the registry for this purpose. The registry is currently at the centre of a debate on the effectiveness of newly developed prostheses (see Clinica No 1257, p 3).
You may also be interested in...
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.